Genetic Disorders Treatment Options Batten Disease Duchenne Muscular Dystrophy Muscular Dystrophy Pediatric Rare Diseases Genetic Conditions Patient Care Neurological Disorders Pediatric Disorders Anemia Epidemiology Creatine Transporter Deficiency Research Foundations Support Organizations Autoimmune Disorders Pediatric Conditions Cancer Treatments Patient Advocacy IDIC 15 Metabolic Disorders Systemic Mastocytosis Emoglobinuria Parossistica Notturna Orphan Diseases Congenital Disorders Mitochondrial Diseases Cardiomyopathy Research MEF2C Haploinsufficiency Syndrome Transthyretin Amyloidosis Desmoid Tumors Orphan Drugs Inherited Anaemias Hereditary Angioedema National Policy for Rare Diseases Liver Diseases Neurofibromatosis Type 1 Alpha-1 Antitrypsin Deficiency Fibrodysplasia Ossificans Progressiva Sarcomas Progressive Lung Diseases Childhood Cancer Orphan Drug Designation Friedreich's Ataxia Brain Tumors Therapeutics Development AnWj-negative Individuals Hereditary Hemorrhagic Telangiectasia Niemann-Pick Disease Arthrogryposis Diagnosis Neurodevelopmental Disorders
The company says the setback does not change its financial outlook.